Dynavax Technologies Corp (NASDAQ:DVAX)
CAPS Rating:
A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.
RSS Headlines
Fool UK
Recs
FDA didn't approve this morning; company will file again soon for more limited label.